The real-time PCR test was developed by Thermo Fisher Scientific and validated by Aeon, and detects 34 different pathogens from vaginal swabs.
The new women's health and STI tests for the BD Max platform are part of a small, focused panel approach which the firm believes will resonate with physicians and labs.
The PCR-based panel tests for the pathogens that cause three types of gynecological infection: bacterial vaginosis, candidiasis, and trichomoniasis.
The method detected differences in the vaginal microbiome that matched up with patients' clinical diagnoses of vaginosis, and also their response to antibiotic treatment.
IMDx gets CE Mark for C. difficile assay on Abbott m2000; Medical Diagnostic Labs launches qPCR panel for bacterial vaginosis; Seegene introduces Anyplex plus MTB/NTM/DR-TB.
Illinois at Urbana-Champaign will lead an effort funded by NIAID to study bacterial metagenomics involved in women's genital tract infections.
Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.
Some science companies will be taking part in next month's March for Science, Fortune reports.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.